A pharmaceutical company announces that it has received Federal Drug Administration approval for a new allergy drug that completely prevents hay fever. The consensus analyst forecast for the company$$s earnings per share $($EPS$)$ is $$5\mathrm{.}00,$ and insiders agree with analyst expectations. They too expect that, with this new drug, earnings will drive the EPS to $$5\mathrm{.}00.$ What will happen when the company releases its next earnings report?